These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10123840)

  • 1. Impact of nosocomial infections on hospital costs.
    Nightingale CH
    Hosp Formul; 1993 Jan; 28 Suppl 1():51-4. PubMed ID: 10123840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of streamlining antibiotic administration.
    Quintiliani R; Cooper BW; Briceland LL; Nightingale CH
    Am J Med; 1987 Apr; 82(4A):391-4. PubMed ID: 3578328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.
    Astagneau P; Fleury L; Leroy S; Lucet JC; Golliot F; Régnier B; Brücker G
    J Hosp Infect; 1999 Aug; 42(4):303-12. PubMed ID: 10467544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct cost of antibiotic therapy prescribed for nosocomial bacteremia. Prospective study during 6 months at a CHU (University Hospital Center)].
    Daumal F; Etienne C; Votte P; Bou P; Canarelli B; Desablens F; Schmit JL; Eb F
    Pathol Biol (Paris); 1998 Jun; 46(6):470-5. PubMed ID: 9769884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach.
    Briceland LL; Nightingale CH; Quintiliani R; Cooper BW; Smith KS
    Arch Intern Med; 1988 Sep; 148(9):2019-22. PubMed ID: 3415406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial infections and misuse of antibiotics in a provincial community hospital, Saudi Arabia.
    Al-Ghamdi S; Gedebou M; Bilal NE
    J Hosp Infect; 2002 Feb; 50(2):115-21. PubMed ID: 11846538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic implications of oral treatment replacing parenteral therapy in antimicrobial chemotherapy.
    Leigh DA
    Chemioterapia; 1988 Dec; 7(6):400-5. PubMed ID: 3219753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The costs of hospital infections in a group of patients in a tertiary-care hospital].
    Juárez-Muñoz IE; Vázquez-Rodríguez A; Games-Eternood J; Sciandra-Rico M; Mercado-Arellano JA; Solórzano-Santos F
    Gac Med Mex; 1999; 135(5):457-62. PubMed ID: 10596485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Every tenth hospitalized patient is given antibiotics for a nosocomial infection].
    Struwe J; Sjögren A
    Lakartidningen; 2002 Aug; 99(32-33):3211-3. PubMed ID: 12219475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
    Rosenthal VD; Guzman S; Migone O; Safdar N
    Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional (intravenous to oral) antibiotic therapy.
    Quintiliani R; Grant E; Quintiliani R
    J Med Liban; 2000; 48(4):233-40. PubMed ID: 11214195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of antimicrobials for the treatment of nosocomial infections.
    Serpanich N; Sermpanich A; Kasempitakpong B
    J Med Assoc Thai; 1995 Jul; 78 Suppl 1():S7-10. PubMed ID: 7666036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
    Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
    J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial infection: the hidden cost in health care.
    Polakavetz SH; Dunne ME; Cook JS
    Hospitals; 1978 Aug; 52(16):101-2, 104, 106. PubMed ID: 669630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact and relevance of antibiotic resistance.
    French GL
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1514-27. PubMed ID: 15978698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.